OR62. The Association Between Cardiovascular Diseases and Underlying Comorbidities in Patients with All Types of Cardiovascular Disease at Sanglah General Hospital Denpasar, Bali, Indonesia In 2021: a Hospital-Based Cross-Sectional Study

Autor: P S Upadhana, I G G Sastrawan, I G A A C Cahyarini, A K Umam, I B R Wibhuti
Rok vydání: 2021
Předmět:
Zdroj: European Heart Journal Supplements. 23
ISSN: 1554-2815
1520-765X
Popis: Background and Aims Cardiovascular disease accompanied by underlying comorbidities increases morbidity, worsens the outcome of therapy and decreases a patient's quality of life. Therefore, this study aims to determine the distribution and association between various comorbidities and cardiovascular diseases. Methods and Results This study was carried out using the analytical observational and cross-sectional design methods. Data were collected from 219 patients diagnosed with all types of cardiovascular diseases (CVD) at Sanglah General Hospital from January 2021 to April 2021. The result showed that the majority of the patients were male (n = 116; 53%) with a median age of 53 (14-80) years. Furthermore, approximately 140 patients (63.9%) had more than one CVD, and comorbid (n = 123, 56.2%). The most common CVD and comorbid found in patients were coronary artery (n = 111; 50.7%) and chronic kidney (n = 162; 74%) diseases, respectively. The strongest associations within CVDs were between valvular and rheumatic heart diseases (PR: 12,121; 95%CI: 3,813-38,535). Meanwhile, diabetes mellitus (PR: 1.38; 95%CI: 1.061-1.797), chronic kidney disease (PR: 1.818; 95%CI: 1.213-2.724), dyslipidemia (PR: 1.715; 95%CI: 1.319-2.230), and obesity (PR: 1.473; 95% CI: 1.123–1.932) were strongly associated with the incidence of coronary artery disease. Patients with diabetes mellitus had a higher risk of having more than one cardiovascular disease (PR: 1.463; 95%CI: 1.016-2.107). Conclusion Cardiovascular disease accompanied by underlying comorbidity has a significant effect on the course of the disease. Early identification and intervention against these comorbidities and CVDs prevents morbidity and improves the patient’s outcome.
Databáze: OpenAIRE
Externí odkaz: